Areas of Focus
- Tumor-targeted drug delivery based on nanotechnology
Work Experience
- 2020-10~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Researcher
- 2014-10~2020-09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Associate Researcher
- 2012-07~2014-09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Assistant Researcher
- 2007-09~2012-06 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - PhD in Science
Academic Background & Achievements
- 2007-09--2012-06 PhD in Science: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Publications
- Co-delivering irinotecan and imiquimod by pH-responsive micelle amplifies anti-tumor immunity against colorectal cancer, Qi Yin, 2023
- Promote intratumoral drug release and penetration to counteract docetaxel-induced metastasis by photosensitizer-modified red blood cell membrane-coated nanoparticle, Qi Yin, 2023
- Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy, Qi Yin, 2023
- Breaking tumor immunosuppressive network by regulating multiple nodes with triadic drug delivery nanoparticles, Qi Yin, 2023
- Nanosized drug delivery systems modulating immunosuppressive microenvironment for improving cancer immunotherapy, Qi Yin, 2022
- Anti-hypoxia nanosized drug delivery systems improving cancer therapy, Qi Yin, 2022
- Nano drug delivery systems improve metastatic breast cancer therapy, Qi Yin, 2021
- Gut microbiota: influence on carcinogenesis and modulation strategies by drug delivery systems to improve cancer therapy, Qi Yin, 2021
- Ternary regulation of tumor microenvironment by heparanase-sensitive micelle-loaded monocytes improves chemo-immunotherapy of metastatic breast cancer, Qi Yin, 2021
- Calcitriol-loaded dual-pH-sensitive micelle counteracts pro-metastasis effect of paclitaxel in triple-negative breast cancer therapy, Qi Yin, 2020
- Tumor microenvironment-responsive docetaxel-loaded micelle combats metastatic breast cancer, Qi Yin, 2019
- In vivo environment-adaptive nanocomplex with tumor cell-specific cytotoxicity enhances T cells infiltration and improves cancer therapy, Qi Yin, 2019
- Cocktail strategy based on spatio-temporally controlled nano device improves therapy of breast cancer, Qi Yin, 2019
Awards
- First Prize (2023): Key technology and application of formulations to improve the in vivo delivery efficiency of poorly soluble drugs
- Second Prize (2020): Basic research on the application of new nano drug delivery systems to overcome tumor chemotherapy resistance
- First Prize (2020): Research on drug delivery systems to improve the efficacy of poorly soluble drugs and the druggability of candidate drugs
- Sanofi-Shanghai Institute of Biological Sciences Outstanding Young Talent Award (2019)
- First Prize (2015): Chinese Pharmaceutical Association Science and Technology Award
- First Prize (2013): Shanghai Pharmaceutical Science and Technology Award
